Chemours, Dupont De Nemours, and Corteva have announced a $110 million settlement with the U.S. state of Ohio to resolve claims linked to toxic "forever chemicals." This agreement aims to address concerns surrounding per- and polyfluoroalkyl substances (PFAS).
Nasdaq reported that the chemical has been associated with various health risks. The settlement covers costs related to the release of PFAS from the companies' facilities, including the Washington Works site situated along the Ohio-West Virginia border, as per Reuters.
Responsibility Distribution for Settlement Costs
According to the agreement, Chemours, a spin-off of DuPont, will bear 50% of the settlement costs, while DuPont will contribute approximately $39 million. Corteva, on the other hand, is expected to cover the remaining expenses. The resolution brings an end to Ohio's claims concerning the release of PFAS, affording the state an opportunity to address this issue comprehensively.
The resolution of the Ohio settlement emphasizes the importance of addressing the wide-reaching implications of PFAS contamination.
Notably, the settlement between the companies and Ohio has triggered a contingency provision outlined in Delaware's 2021 PFAS settlement with the same entities.
This provision requires an additional payment of $25 million to the state of Delaware and the original $50 million settlement if a similar agreement is reached within eight years with another state, amounting to over $50 million. This provision underlines the accountability held by chemical manufacturers in addressing the concerns associated with PFAS contamination.
Legal Battles Surrounding PFAS
Chemical manufacturers have faced numerous lawsuits in recent years regarding alleged PFAS contamination. In a significant ruling, a U.S. appeals court rejected a lower court's decision that would have allowed approximately 11.8 million Ohio residents to sue 10 PFAS manufacturers as a collective group. The legal landscape demonstrates the complexity surrounding PFAS-related claims and the efforts to hold responsible parties accountable for their actions.
In June, 3M agreed to a $10.3 billion settlement to address hundreds of claims alleging the company had contaminated public drinking water with PFAS. Similarly, Chemours, DuPont, and Corteva reached a separate settlement with U.S. water providers, amounting to $1.19 billion.
These settlements underscore the growing recognition within the industry regarding the need to address PFAS-related concerns and the responsibility manufacturers bear in ensuring the safety of their products and practices.
Photo: DuPont Newsroom


U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Bolivia’s Ex-President Luis Arce Detained in Embezzlement Probe
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Brazil Arrests Former Peruvian Foreign Minister Augusto Blacker Miller in International Fraud Case
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
New Epstein Photos Surface Showing Trump as Lawmakers Near Document Release Deadline
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
DOJ Sues Loudoun County School Board Over Transgender Locker Room Policy
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute
US Charges Two Men in Alleged Nvidia Chip Smuggling Scheme to China
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Supporters Gather Ahead of Verdict in Jimmy Lai’s Landmark Hong Kong National Security Trial
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 



